Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations.

Morgan JC, Dhall R, Rubens R, Khanna S, Gupta S.

Parkinsons Dis. 2018 Oct 22;2018:9763057. doi: 10.1155/2018/9763057. eCollection 2018.

2.

Insecticide resistance in Anopheles gambiae from the northern Democratic Republic of Congo, with extreme knockdown resistance (kdr) mutation frequencies revealed by a new diagnostic assay.

Lynd A, Oruni A, Van't Hof AE, Morgan JC, Naego LB, Pipini D, O'Kines KA, Bobanga TL, Donnelly MJ, Weetman D.

Malar J. 2018 Nov 6;17(1):412. doi: 10.1186/s12936-018-2561-5.

3.

Conversations about pictorial cigarette pack warnings: Theoretical mechanisms of influence.

Morgan JC, Golden SD, Noar SM, Ribisl KM, Southwell BG, Jeong M, Hall MG, Brewer NT.

Soc Sci Med. 2018 Dec;218:45-51. doi: 10.1016/j.socscimed.2018.09.063. Epub 2018 Oct 3.

PMID:
30340152
4.

What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry.

Parashos SA, Bloem BR, Browner NM, Giladi N, Gurevich T, Hausdorff JM, He Y, Lyons KE, Mari Z, Morgan JC, Post B, Schmidt PN, Wielinski CL.

Neurol Clin Pract. 2018 Jun;8(3):214-222. doi: 10.1212/CPJ.0000000000000461. Erratum in: Neurol Clin Pract. 2018 Aug;8(4):278.

PMID:
30105161
5.

Similarities and Differences in Tobacco Control Research Findings From Convenience and Probability Samples.

Jeong M, Zhang D, Morgan JC, Ross JC, Osman A, Boynton MH, Mendel JR, Brewer NT.

Ann Behav Med. 2018 Jul 20. doi: 10.1093/abm/kay059. [Epub ahead of print]

PMID:
30052702
6.

Niacin modulates macrophage polarization in Parkinson's disease.

Wakade C, Giri B, Malik A, Khodadadi H, Morgan JC, Chong RK, Baban B.

J Neuroimmunol. 2018 Jul 15;320:76-79. doi: 10.1016/j.jneuroim.2018.05.002. Epub 2018 May 4.

7.

Cigarette pack messages about toxic chemicals: a randomised clinical trial.

Brewer NT, Jeong M, Mendel JR, Hall MG, Zhang D, Parada H Jr, Boynton MH, Noar SM, Baig SA, Morgan JC, Ribisl KM.

Tob Control. 2018 Apr 13. pii: tobaccocontrol-2017-054112. doi: 10.1136/tobaccocontrol-2017-054112. [Epub ahead of print]

8.

Candidate-gene based GWAS identifies reproducible DNA markers for metabolic pyrethroid resistance from standing genetic variation in East African Anopheles gambiae.

Weetman D, Wilding CS, Neafsey DE, Müller P, Ochomo E, Isaacs AT, Steen K, Rippon EJ, Morgan JC, Mawejje HD, Rigden DJ, Okedi LM, Donnelly MJ.

Sci Rep. 2018 Feb 13;8(1):2920. doi: 10.1038/s41598-018-21265-5.

9.

Maneuvering Together, Apart, and at Odds: Residents' Care Convoys in Assisted Living.

Kemp CL, Ball MM, Morgan JC, Doyle PJ, Burgess EO, Perkins MM.

J Gerontol B Psychol Sci Soc Sci. 2018 Apr 16;73(4):e13-e23. doi: 10.1093/geronb/gbx184.

PMID:
29401238
10.

Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle?

Sharma A, Kurek J, Morgan JC, Wakade C, Rao SSC.

Curr Gastroenterol Rep. 2018 Jan 19;20(1):1. doi: 10.1007/s11894-018-0609-x. Review.

PMID:
29350301
11.

Teaching Video NeuroImages: Oculogyric crisis in treated Parkinson disease.

Davis JL, Kurek JA, Morgan JC, Sethi KD.

Neurology. 2018 Jan 16;90(3):e263. doi: 10.1212/WNL.0000000000004816. No abstract available.

PMID:
29335315
12.

Brand switching and toxic chemicals in cigarette smoke: A national study.

Mendel JR, Baig SA, Hall MG, Jeong M, Byron MJ, Morgan JC, Noar SM, Ribisl KM, Brewer NT.

PLoS One. 2018 Jan 11;13(1):e0189928. doi: 10.1371/journal.pone.0189928. eCollection 2018.

13.

Insights into Pathophysiology from Medication-induced Tremor.

Morgan JC, Kurek JA, Davis JL, Sethi KD.

Tremor Other Hyperkinet Mov (N Y). 2017 Nov 22;7:442. doi: 10.7916/D8FJ2V9Q. eCollection 2017. Review.

14.

Where Policy Meets Practice: Employer Perspectives on Scheduling and Hours for Home Care Aides.

Nisbet E, Morgan JC.

J Appl Gerontol. 2017 Nov 1:733464817739153. doi: 10.1177/0733464817739153. [Epub ahead of print]

PMID:
29164997
15.

Frequency and Content of Conversations About Pictorial Warnings on Cigarette Packs.

Morgan JC, Southwell BG, Noar SM, Ribisl KM, Golden SD, Brewer NT.

Nicotine Tob Res. 2018 Jun 7;20(7):882-887. doi: 10.1093/ntr/ntx180.

PMID:
29059415
16.

Identifying principles for effective messages about chemicals in cigarette smoke.

Noar SM, Kelley DE, Boynton MH, Morgan JC, Hall MG, Mendel JR, Ribisl KM, Brewer NT.

Prev Med. 2018 Jan;106:31-37. doi: 10.1016/j.ypmed.2017.09.005. Epub 2017 Sep 8.

PMID:
28890353
17.

National randomized controlled trial of virtual house calls for Parkinson disease.

Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W; Connect.Parkinson Investigators.

Neurology. 2017 Sep 12;89(11):1152-1161. doi: 10.1212/WNL.0000000000004357. Epub 2017 Aug 16.

18.

Cognitive workload across the spectrum of cognitive impairments: A systematic review of physiological measures.

Ranchet M, Morgan JC, Akinwuntan AE, Devos H.

Neurosci Biobehav Rev. 2017 Sep;80:516-537. doi: 10.1016/j.neubiorev.2017.07.001. Epub 2017 Jul 12. Review.

PMID:
28711663
19.

A response from Morgan, Byron, Baig, Stepanov and Brewer.

Morgan JC, Byron MJ, Baig SA, Stepanov I, Brewer NT.

J Behav Med. 2017 Aug;40(4):684. doi: 10.1007/s10865-017-9865-8. Epub 2017 Jun 13. No abstract available.

20.

Effective Message Elements for Disclosures About Chemicals in Cigarette Smoke.

Kelley DE, Boynton MH, Noar SM, Morgan JC, Mendel JR, Ribisl KM, Stepanov I, Nylander-French LA, Brewer NT.

Nicotine Tob Res. 2018 Aug 14;20(9):1047-1054. doi: 10.1093/ntr/ntx109.

PMID:
28521063
21.

Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort.

Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, Mari Z, Morgan JC, Wills AM, Lee SL, Parashos SA; NINDS NET-PD Investigators.

J Neurol Sci. 2017 Jun 15;377:137-143. doi: 10.1016/j.jns.2017.04.011. Epub 2017 Apr 11.

22.

Social identity and support for counteracting tobacco company marketing that targets vulnerable populations.

Baig SA, Pepper JK, Morgan JC, Brewer NT.

Soc Sci Med. 2017 Jun;182:136-141. doi: 10.1016/j.socscimed.2017.03.052. Epub 2017 Apr 18.

23.

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE.

Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316. Review.

24.

How people think about the chemicals in cigarette smoke: a systematic review.

Morgan JC, Byron MJ, Baig SA, Stepanov I, Brewer NT.

J Behav Med. 2017 Aug;40(4):553-564. doi: 10.1007/s10865-017-9823-5. Epub 2017 Feb 21. Review.

25.

Public understanding of cigarette smoke constituents: three US surveys.

Brewer NT, Morgan JC, Baig SA, Mendel JR, Boynton MH, Pepper JK, Byron MJ, Noar SM, Agans RP, Ribisl KM.

Tob Control. 2016 Sep;26(5):592-599. doi: 10.1136/tobaccocontrol-2015-052897. Epub 2016 Dec 6.

26.

Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1.

Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, Leehey M, Zweig RM, Nicholas AP, Bodis-Wollner I, Willis A, Kieburtz K, Tilley BC; NINDS NET-PD Investigators.

J Parkinsons Dis. 2017;7(1):117-127. doi: 10.3233/JPD-160965.

PMID:
27911341
27.

Exposing the Backstage: Critical Reflections on a Longitudinal Qualitative Study of Residents' Care Networks in Assisted Living.

Kemp CL, Ball MM, Morgan JC, Doyle PJ, Burgess EO, Dillard JA, Barmon CE, Fitzroy AF, Helmly VE, Avent ES, Perkins MM.

Qual Health Res. 2017 Jul;27(8):1190-1202. doi: 10.1177/1049732316668817. Epub 2016 Sep 19.

28.

Social Interactions as a Source of Information about E-Cigarettes: A Study of U.S. Adult Smokers.

Hall MG, Pepper JK, Morgan JC, Brewer NT.

Int J Environ Res Public Health. 2016 Aug 5;13(8). pii: E788. doi: 10.3390/ijerph13080788.

29.

Fitness-to-drive Disagreements in Individuals With Dementia.

Ranchet M, Tant M, Akinwuntan AE, Morgan JC, Devos H.

Gerontologist. 2017 Oct 1;57(5):833-837. doi: 10.1093/geront/gnw119.

PMID:
27496014
30.

Treating the Motor Symptoms of Parkinson Disease.

Morgan JC, Fox SH.

Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1064-85. doi: 10.1212/CON.0000000000000355. Review.

PMID:
27495198
31.

Evaluation of a Laughter-based Exercise Program on Health and Self-efficacy for Exercise.

Greene CM, Morgan JC, Traywick LS, Mingo CA.

Gerontologist. 2017 Nov 10;57(6):1051-1061. doi: 10.1093/geront/gnw105.

PMID:
27492618
32.

'Nature or nurture': survival rate, oviposition interval, and possible gonotrophic discordance among South East Asian anophelines.

Derek Charlwood J, Nenhep S, Sovannaroth S, Morgan JC, Hemingway J, Chitnis N, Briët OJ.

Malar J. 2016 Jul 12;15(1):356. doi: 10.1186/s12936-016-1389-0.

33.

Juvenile onset Parkinsonism with "pure nigral" degeneration and POLG1 mutation.

Mehta SH, Dickson DW, Morgan JC, Singleton AB, Majounie E, Sethi KD.

Parkinsonism Relat Disord. 2016 Sep;30:83-5. doi: 10.1016/j.parkreldis.2016.06.013. Epub 2016 Jun 21. No abstract available.

34.

Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America.

Goudreau JL, Pérez A, Aminoff MJ, Boyd JT, Burau KD, Christine CW, Leehey M, Morgan JC; NET-PD Investigators.

J Neurol Sci. 2016 Jul 15;366:74-81. doi: 10.1016/j.jns.2016.04.021. Epub 2016 Apr 16.

PMID:
27288780
35.

Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.

Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I, Hushpulian DM, Kaddour-Djebbar I, Bollag WB, Morgan JC, Ratan RR, Starkov AA, Beal MF, Thomas B.

J Neurosci. 2016 Jun 8;36(23):6332-51. doi: 10.1523/JNEUROSCI.0426-16.2016.

36.

Use of a driving simulator to improve on-road driving performance and cognition in persons with Parkinson's disease: A pilot study.

Devos H, Morgan JC, Onyeamaechi A, Bogle CA, Holton K, Kruse J, Sasser S, Akinwuntan AE.

Aust Occup Ther J. 2016 Dec;63(6):408-414. doi: 10.1111/1440-1630.12263. Epub 2016 Apr 13.

PMID:
27071987
37.

Effects of the spatial repellent metofluthrin on landing rates of outdoor biting anophelines in Cambodia, Southeast Asia.

Charlwood JD, Nenhep S, Protopopoff N, Sovannaroth S, Morgan JC, Hemingway J.

Med Vet Entomol. 2016 Jun;30(2):229-34. doi: 10.1111/mve.12168. Epub 2016 Mar 15.

PMID:
26991881
38.

ADCY5 mutations are another cause of benign hereditary chorea.

Morgan JC, Kurek JA, Davis J, Sethi KD.

Neurology. 2016 Mar 8;86(10):978-9. doi: 10.1212/WNL.0000000000002479. No abstract available.

PMID:
26952302
39.

National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.

Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W.

Telemed J E Health. 2016 Jul;22(7):590-8. doi: 10.1089/tmj.2015.0191. Epub 2016 Feb 17.

40.

"My First Thought was Croutons": Perceptions of Cigarettes and Cigarette Smoke Constituents Among Adult Smokers and Nonsmokers.

Moracco KE, Morgan JC, Mendel J, Teal R, Noar SM, Ribisl KM, Hall MG, Brewer NT.

Nicotine Tob Res. 2016 Jul;18(7):1566-74. doi: 10.1093/ntr/ntv281. Epub 2015 Dec 17.

41.

Case report of optic atrophy in Dentatorubropallidoluysian Atrophy (DRPLA).

Silver MR, Sethi KD, Mehta SH, Nichols FT, Morgan JC.

BMC Neurol. 2015 Dec 18;15:260. doi: 10.1186/s12883-015-0520-0.

42.

Interprofessional education increases knowledge, promotes team building, and changes practice in the care of Parkinson's disease.

Cohen EV, Hagestuen R, González-Ramos G, Cohen HW, Bassich C, Book E, Bradley KP, Carter JH, Di Minno M, Gardner J, Giroux M, González MJ, Holten S, Joseph R, Kornegay DD, Simpson PA, Tomaino CM, Vandendolder RP, Walde-Douglas M, Wichmann R, Morgan JC.

Parkinsonism Relat Disord. 2016 Jan;22:21-7. doi: 10.1016/j.parkreldis.2015.11.001. Epub 2015 Nov 6.

PMID:
26620547
43.

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B; NINDS NET-PD Investigators.

J Parkinsons Dis. 2015;5(4):731-6. doi: 10.3233/JPD-150666.

44.

Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects.

Wakade C, Chong R, Bradley E, Morgan JC.

Clin Case Rep. 2015 Jul;3(7):635-7. doi: 10.1002/ccr3.232. Epub 2015 Jun 11.

45.

Remote ischemic conditioning: a treatment for vascular cognitive impairment.

Hess DC, Khan MB, Hoda N, Morgan JC.

Brain Circ. 2015 Jul-Dec;1(2):133-139. doi: 10.4103/2394-8108.172885. Epub 2015 Dec 31.

46.

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.

Langone A, Steinberg SM, Gedaly R, Chan LK, Shah T, Sethi KD, Nigro V, Morgan JC; STRATO Investigators.

Clin Transplant. 2015 Sep;29(9):796-805. doi: 10.1111/ctr.12581. Epub 2015 Aug 6.

47.

When a discriminating dose assay is not enough: measuring the intensity of insecticide resistance in malaria vectors.

Bagi J, Grisales N, Corkill R, Morgan JC, N'Falé S, Brogdon WG, Ranson H.

Malar J. 2015 May 20;14:210. doi: 10.1186/s12936-015-0721-4.

48.

Defining the Eye-of-the-Tiger Sign.

Sethi KD, Mehta SH, Morgan JC.

JAMA Neurol. 2015 May;72(5):606. doi: 10.1001/jamaneurol.2015.0144. No abstract available.

PMID:
25961178
49.

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators, Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, Cines M, Dahodwala N, Derwent L, Dewey RB Jr, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM.

JAMA. 2015 Feb 10;313(6):584-93. doi: 10.1001/jama.2015.120.

50.

Parkinson's disease severity and use of dopaminergic medications.

Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL; NINDS NET-PD Investigators.

Parkinsonism Relat Disord. 2015 Mar;21(3):297-9. doi: 10.1016/j.parkreldis.2014.10.016. Epub 2014 Dec 15.

Supplemental Content

Loading ...
Support Center